18.08.2023
Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Synspira
Synspira Therapeutics develops treatments for cystic fibrosis and rare diseases.
Sector
Subsector
Location
total rounds
total raised
viDA Therapeutics
viDA Therapeutics develops treatments for chronic inflammatory and age-related diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Palatin Technologies
Palatin is a biopharmaceutical company developing medicines that target the melanocortin peptide receptor system.
Sector
Subsector
Location
total rounds
total raised
AsclepiX Therapeutics
AsclepiX Therapeutics is a biotech company that develops novel therapeutics for retinal diseases and cancer.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds9
Number of Funding Rounds
Money Raised
Their latest funding was raised on 18.04.2023. Their latest round Post-IPO Equity
Co-Investors
Investors11
Number of lead investors
Number of investors
Pappas Capital
Pappas Capital invests in life science companies across the United States and Canada.
Sector
Subsector
Location
count Of Investments
count Of Exists
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
RA Capital Management
RA Capital Management is a Boston-based investment advisor that specializes in the life-sciences and drug development sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
Gil Van Bokkelen
Gil Van Bokkelen is the Chairman & CEO, Athersys, Inc.
current job
organization founded
Gil Van Bokkelen
John Harrington
Dr. Harrington co-founded Athersys in October 1995 and has served as Athersys' Executive Vice President and Chief Scientific Officer and as a director since Athersys' founding. Dr. Harrington led the development of the RAGE technology as well as its application for gene discovery, drug discovery and commercial protein production applications. He is a listed inventor on 20 issued or pending U.S. patents, has authored 20 scientific publications, and has received numerous awards for his work, including being named one of the top international young scientists by MIT Technology Review in 2002. Dr. Harrington has overseen the therapeutic product development programs at Athersys since their inception, and during his career he has also held positions at Amgen and Scripps Clinic. He received his Ph.D. in Cancer Biology from Stanford University and his B.A. in Biochemistry and Cell Biology from the University of California at San Diego.
current job
organization founded
John Harrington
Employee Profiles43
Maia Hansen
Senior Vice President, Operations and Supply Chain
Alice Valentin-Torres
Senior scientist, immunologist, department of regenerative med
Chris Bruns
Senior manager, clinical manufacturing and supply
Activity
Recent News9
The graph reveals the ratio (%) of positive news articles in a chosen time range